<DOC>
	<DOC>NCT01735201</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of 3 doses of AGN-199201 once and twice daily compared to vehicle for the treatment of moderate to severe facial erythema associated with rosacea.</brief_summary>
	<brief_title>AGN-199201 for the Treatment of Erythema With Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Erythema</mesh_term>
	<criteria>Redness of the skin caused by rosacea â‰¥3 inflammatory lesions Laser lightsource or other energy based therapy in the last 6 months Any prescription or over the counter product for the treatment of acne or rosacea in the last 14 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>